Akt1

Akt1

Akt1 詳細

Molecule Name
Serine/threonine-protein kinase AKT1
分子の別称
AKT1,PKB,RAC,RAC-PK-alpha,PKB alpha
Drug Development Progress
治験薬の数24
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
EC:2.7.11.1,EC 2.7.11,Proto-oncogene c-Akt,Protein kinase B,RAC,RAC-PK-alpha,PKB alpha,RAC-alpha serine/threonine-protein kinase,AKT1,AKT Serine/Threonine Kinase 1,V-Akt Murine Thymoma Viral Oncogene Homolog 1,Protein Kinase B Alpha,PKB,V-Akt Murine Thymoma Viral Oncogene-Like Protein 1,Serine-Threonine Protein Kinase,Rac Protein Kinase Alpha,EC 2.7.11.1,PKB-ALPHA,RAC-ALPHA,AKT1m,PRKBA,CWS6,AKT
バックグランド
RAC-alpha serine/threonine-protein kinase (AKT1) is also known PKB, Protein kinase B alpha, PKB alpha, Proto-oncogene c-Akt and RAC-PK-alpha, which belongs to the protein kinase superfamily, AGC Ser/Thr protein kinase family and RAC subfamily and is expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase).

Akt1 製品リスト

Species
  • Human(1)
Tag
  • His Tag & Strep Tag(1)
Host
  • HEK293(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
Akt1
Human Akt1 Protein, His,Strep II Tag
Human
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
AfuresertibGSK-2110183; GSK-2110183B; GSK-2110183C; GSK-21110183; LAE-002; LAE002; ASB-183Phase 3 ClinicalGlaxosmithkline Plc, Novartis Pharma Ag
Adenocarcinoma; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Hematologic Neoplasms; Histiocytosis, Langerhans-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Metastatic breast cancer; Multiple Myeloma; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms
詳細
IpatasertibRG-7440; GCD-0068; GDC-0068; RO-5532961Phase 3 ClinicalArray Biopharma, Genentech Inc
Adenocarcinoma; Breast Neoplasms; Carcinoma, Endometrioid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Endometrial Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Glioblastoma; Head and Neck Neoplasms; Hepatic Insufficiency; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lip Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Metastatic breast cancer; Mouth Neoplasms; Multiple Myeloma; Neoplasm Metastasis; Neoplasm, Residual; Neoplasms; Neoplasms, Unknown Primary; Nose Neoplasms; Oropharyngeal Neoplasms; Ovarian Neoplasms; Paranasal Sinus Diseases; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urogenital Neoplasms
詳細
NTQ-1062NTQ-1062; NTQ1062Phase 3 ClinicalNanjing Zhengda Tianqing Pharmaceutical Co Ltd
Breast Neoplasms; HR-positive breast cancer; Solid tumours
詳細
SR-0379SR-0379Phase 3 ClinicalFunPep Co Ltd
Skin Ulcer
詳細
Triciribine PhosphateNSC-154020; PTX-002; API-2; TCN-P; VQD-002-ORAL; VQD-002; NSC-280594; PTX-200Phase 2 ClinicalNational Cancer Institute
Breast Neoplasms; Hematologic Neoplasms; Leukemia; Neoplasms; Ovarian Neoplasms
詳細
MiransertibMK-7075; ARQ-092Phase 2 ClinicalArqule Inc
Endometrial Neoplasms; Lymphoma; Neoplasms; Ovarian Neoplasms; PIK3CA-Related Overgrowth Spectrum; Proteus Infections; Proteus Syndrome; Solid tumours
詳細
Ursolic AcidNSC-167406; NSC-4060Phase 2 ClinicalUniversity Of Guadalajara
Breast Neoplasms; Carcinoma, Hepatocellular; Cholangitis, Sclerosing; Colonic Neoplasms; Colorectal Neoplasms; Insulin Resistance; Liver Neoplasms; Lung Neoplasms; Metabolic Syndrome; Muscular Atrophy; Pancreatic Neoplasms; Paraplegia; Prostatic Neoplasms; Quadriplegia; Sarcopenia; Spinal Cord Injuries; Stomach Neoplasms
詳細
Uprosertib/Trametinib Dimethyl SulfoxidePhase 2 ClinicalNovartis Pharma Ag
Endometrial Neoplasms; Leukemia, Myeloid, Acute; Uterine Cervical Neoplasms
詳細
Selumetinib sulfate/MK-2206Phase 2 ClinicalAstrazeneca Plc, Merck & Co Inc
Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rectal Neoplasms; Triple Negative Breast Neoplasms
詳細
UprosertibGSK-2141795; GSK-2141795C; UPB-795; LAE-003; GSK-795Phase 2 ClinicalGlaxosmithkline Plc, National Cancer Institute, Novartis Pharma Ag
Adenocarcinoma, Clear Cell; Breast Neoplasms; Endometrial Neoplasms; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Melanoma; Multiple Myeloma; Neoplasms; Skin Melanoma; Solid tumours; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Uveal melanoma
詳細
RX-0301RX-0201 nanoliposomal; RX-0201 Nano; HC0301; RX-0201-N; RX-0301; WGI-0301; RX-0201改良型Phase 2 ClinicalRexahn Pharmaceuticals Inc
Carcinoma, Hepatocellular; Liver Neoplasms
詳細
TER-2013TER-2013Phase 2 ClinicalTerremoto Biosciences Inc
Breast Neoplasms; Carcinoma, Squamous Cell; Endometrial Neoplasms; Esophageal Squamous Cell Carcinoma; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms
詳細
MK-2206MK2206; MK-2206; BIND-2206; NSC-749607Phase 2 ClinicalMerck Sharp & Dohme Corp
Adenocarcinoma; Adenocarcinoma of Lung; Adenocarcinoma, Bronchiolo-Alveolar; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Angioimmunoblastic T-cell Lymphoma; Bile Duct Neoplasms; Blastic Plasmacytoid Dendritic Cell Neoplasm; Breast Neoplasms; Breast Neoplasms, Male; Burkitt Lymphoma; Carcinoma, Adenoid Cystic; Carcinoma, Adenosquamous; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Central Nervous System Lymphoma; Cholangiocarcinoma; Chronic eosinophilic leukemia (CEL); Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Gallbladder Neoplasms; Glioma; Hodgkin Disease; Intraocular Lymphoma; Kidney Neoplasms; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Hairy Cell; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Mast-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myelogenous,
詳細
HZB-0071HZB-0071Phase 1 ClinicalHeilongjiang Zbd Pharmaceutical Co Ltd, Wuxi Apptec Co Ltd
Neoplasms
詳細
RupitasertibDIACC3010; M-2698; MSC-2363318A; DIACC-3010Phase 1 ClinicalEmd Serono Inc
Breast Neoplasms; Glioblastoma; Solid tumours; Stomach Neoplasms
詳細
CMX-2043LIP-EA; CMX-2043; R-LIP-EA-OHPhase 1 ClinicalIschemix Llc
Angina, Unstable; Brain Injuries, Traumatic; Cardiovascular Diseases; Coronary Artery Disease; Non-ST Elevated Myocardial Infarction
詳細
TER-1754TER-1754Phase 1 ClinicalTerremoto Biosciences Inc
Telangiectasia, Hereditary Hemorrhagic
詳細
HonokiolPhase 1 Clinical
Carcinoma, Non-Small-Cell Lung; Gingival Diseases
詳細
ATV-1601ATV-1601Phase 1 ClinicalAtavistik Bio Inc
Breast Diseases; Breast Neoplasms; Carcinoma, Endometrioid; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Urogenital Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms
詳細
ALTA-2618ALTA-2618Phase 1 ClinicalAlterome Therapeutics Inc
Breast Neoplasms; Endometrial Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours
詳細
TQB-3912TQB3912; TQB-3912Phase 1 ClinicalJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Breast Neoplasms; HR-positive breast cancer; Neoplasms; Prostatic Neoplasms
詳細
Hu-7691Hu-7691Phase 1 ClinicalZhejiang University
Neoplasms; Solid tumours
詳細
Oxysterols (Intsel Chimos)ClinicalCentre National De La Recherche Scientifique (Cnrs)
Glioma
詳細
AKT1 inhibitors(Atavistik Bio Inc)ClinicalAtavistik Bio Inc
Telangiectasia, Hereditary Hemorrhagic; Vascular Malformations
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
CapivasertibAZD-5363ApprovedAstex Pharmaceuticals Inc, Cancer Research Technology, The Institute Of Cancer Research, LondonTruqap, TRUQAP, 荃科得United StatesBreast NeoplasmsAstrazeneca Pharmaceuticals Lp2023-11-16
Breast Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Glioma; Head and Neck Neoplasms; Hematologic Neoplasms; Hormone-Sensitive Prostate Neoplasms; HR-positive breast cancer; Liver Neoplasms; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Metastatic breast cancer; Multiple Myeloma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Skin Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms
詳細
Customer Reviews